Startups
Rezo is a different kind of biopharma company. Our mission is to dramatically increase the success rate of drug development by building a disease-agnostic, fully-integrated, network biology platform that will redefine our understanding of human disease and ability to treat it.
Our Founders and members of the Board are a group of esteemed, world-class scientists from the University of California, San Francisco: Nevan Krogan, Kevan Shokat, Sourav Bandyopadhyay, Natalia Jura, as well as renowned biotech executives George Scangos and Norbert Bischofberger. These leaders bring with them a strong track record of amazing discoveries and scientific breakthroughs, leading to very successful companies and many FDA approved drugs.
Our Founders and members of the Board are a group of esteemed, world-class scientists from the University of California, San Francisco: Nevan Krogan, Kevan Shokat, Sourav Bandyopadhyay, Natalia Jura, as well as renowned biotech executives George Scangos and Norbert Bischofberger. These leaders bring with them a strong track record of amazing discoveries and scientific breakthroughs, leading to very successful companies and many FDA approved drugs.
Overview
Location
United States, California, San Francisco
Employees
1-10
Total raised
$78M
Investors 3
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Hawktail Management | hawktail.com | |
| Nov 27, 2022 | SR One | srone.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 22, 2022 | Rezo Therapeutics Raises $78M in Series A Funding | Rezo Therapeutics, San Francisco, CA-based biotechnology company, raised $78M in Series A funding. The round was led by SR One, a16z Bio + Health, and Norwest Venture Partners, and also included SV Angel, Liquid 2 Ventures, and Hawktail. Th... |
| Rezo Therapeutics | “Rezo is pioneering an integrated approach to drug discovery to enabling the pinpointing of targets and the development of therapies with unprecedented clarity and speed.” |
Reviews 0
FAQ about Rezo Therapeutics
How much funding has Rezo Therapeutics raised?
Rezo Therapeutics has raised $78M in total across 1 funding round.
Who has invested in Rezo Therapeutics?
Parsers VC lists 3 investors of Rezo Therapeutics, among them SR One and Hawktail Management.
What has the press written about Rezo Therapeutics?
Parsers VC has collected 3 articles mentioning Rezo Therapeutics, among them “Rezo Therapeutics Raises $78M in Series A Funding” (Nov 22, 2022) and “Rezo Therapeutics”.
Is Rezo Therapeutics still active?
Yes, Rezo Therapeutics is active; its latest activity on Parsers VC dates from Nov 27, 2022.